InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,048.42
(
0.00%
)
US TECH 100
17,125.20
(
0.87%
)
Dow Jones
38,085.80
(
0.00%
)
Brent Oil
88.54
(
0.44%
)
Bitcoin
64,341.56
(
-0.22%
)
Post# of 251606
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119484
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: marthambles post# 211497

Thursday, 05/25/2017 10:58:40 AM

Thursday, May 25, 2017 10:58:40 AM

Post# of 251606
RVNC—The proprietary peptide in RT002’s formulation reduces (but does not eliminate) post-injection diffusion of the toxin, so more toxin remains at the injection site, which is where you want it for the desired therapeutic or cosmetic effect. What injectors and users perceive as RT002’s longer duration of action is actually slower loss of toxin at the injection site, compared to Botox and other commercial botulinum-toxin products.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up